Post partum follow-up Dysglycemia IADPSG Asian Indians South Asians A B S T R A C T Aim: To determine postpartum glucose tolerance status among women with gestational diabetes mellitus (GDM) recruited under the Women In India with GDM Strategy (WINGS) Model of Care (MOC). Methods: Through the WINGS MOC programme, 212 women with GDM were followed till delivery between November 2013 and August 2015. All women were advised to return for a postpartum oral glucose tolerance test (OGTT) 6-12 weeks after delivery. A multivariate logistic regression (MLR) model was developed to identify the risk factors for postpartum dysglycemia which was defined as presence of diabetes (DM) or prediabetes. Results: 203/212(95.8%) women completed their postpartum OGTT. Of the 161 women (79.3%) who came back for the test between 6 and 12 weeks, 2(1.2%) developed DM, 5 (3.1%), isolated IFG, 13(8.1%), isolated IGT and 5(3.1%) combined IFG/IGT [dysglycemia 25
Introduction
With the prevalence of type 2 diabetes (T2DM) and prediabetes growing in epidemic proportions, it is extremely important to implement strategies to delay or prevent the onset of T2DM among high risk populations. The incidence of gestational diabetes mellitus (GDM), the most common metabolic disorder during pregnancy, is also increasing worldwide owing to advancing maternal age and increasing obesity rates [1, 2] . Women with previous history of GDM are at seven fold higher risk of developing T2DM in the future compared to their counterparts without GDM [3, 4] . GDM also confers an increased risk of short term and long term health consequences such as preeclampsia, fetal macrosomia, shoulder dystocia and cesarean delivery [5, 6] . This calls for improved screening and treatment for GDM with the aim of improving maternal and fetal outcomes [7, 8] .
The American Diabetes Association (ADA) recommends that women with GDM be reassessed for glycemic status at 6 weeks postpartum [9] . The Fourth International Workshop on GDM also recommended that glucose tolerance should be reevaluated 6-12 weeks postpartum [10] . Despite the elevated risk for diabetes and the recommendations for close follow-up, opportunities for postpartum screening are frequently missed [11] [12] [13] [14] [15] [16] [17] . Postpartum screening rates usually vary from 14% in usual care, to 60% in randomized control trials [18] . The Translating Research Into Action for Diabetes (TRIAD) study has shown that although rates of postpartum screening have increased since the 1990s, it was still only 53.8% in 2006 [11] .
Studies have shown that conversion to T2DM following GDM occurs earlier in South Asians compared to other ethnic groups [19] [20] [21] . In the current study, we sought to determine the frequency of dysglycemia in the early postpartum period, and to identify risk factors predicting postpartum dysglycemia in Asian Indian women with GDM followed prospectively throughout their pregnancy.
Methodology
The Women In India with GDM Strategy (WINGS) is a project undertaken by the International Diabetes Federation (IDF) and the Madras Diabetes Research Foundation (MDRF), Chennai, India with the support of Abbott Fund, to tackle the rising problem of GDM in low-middle income countries (LMIC) such as India [22] . The project was piloted in Chennai, India, with the aim of developing a model approach to care in LMICs to confront the widespread challenges in GDM screening and management. A WINGS GDM Model of Care (MOC) was developed and carried out in collaboration with several health centers in Tamil Nadu, India. According to the WINGS GDM MOC protocol, pregnant women <28 weeks of gestation were approached for screening for GDM and recruited under the model. For the purpose of this paper, ''booking visit" refers to the first antenatal visit of the pregnant woman to the collaborating health center at which point they were screened. All baseline data collection was done at this booking visit, including anthropometry and body weight.
Sample size was calculated using EpiTools software as was as follows: with 95% confidence interval (CI), desired precision estimate of ±0.02(2%), based on previous prevalence rate of 17.8% [23] and drop-out rate of 20%, the sample size was estimated to be 1080.
Under the IDF WINGS MOC, after screening 1124 pregnant women, 247 women were diagnosed with GDM using the International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria and 3 were identified as having overt diabetes. Of the 247 women with GDM, 212 were followed up throughout their pregnancy and their pregnancy outcomes were measured. The remaining 35 women moved to their maternal hometown for continuing their antenatal care and delivered there and hence could not be followed up. The 212 women who were followed under the MOC were constantly reminded about the importance of postpartum follow-up testing and were advised to return for the same 6-12 weeks after delivery. All women who came for the follow-up testing were assessed by doing an oral glucose tolerance test (OGTT) using a 82.5 g oral glucose load (equivalent to 75 g of anhydrous glucose) after an overnight fast of at least 8 h. Venous samples were drawn at fasting and 1 h and 2 h after the glucose load.
Blood samples were collected in sodium fluoride/Na2 EDTA vacutainer tubes to prevent glycolysis. Samples were transported to a central laboratory within one hour of collection in cool boxes which had gel packs to maintain the temperature between 2 and 8°C. Plasma glucose was measured using an autoanalyser AU2700, (Beckman, Fullerton, CA). The intra-and inter assay coefficients of variation for the biochemical assays ranged between 3.1% and 7.6%. The central laboratory is certified by the College of American Pathologists (CAP), USA and the National Accreditation Board for Testing and Calibration Laboratories (NABL), Government of India. The study was approved by the Independent Ethics Committee of the Madras Diabetes Research Foundation (MDRF), and written informed consent was obtained from all participating women.
2.1.

Statistical analysis
Analyses of data was done using Windows based SPSS statistical package (version 15.0, Chicago, IL). Descriptive analyses were performed for specific variables between women converting to diabetes and non converters and unadjusted comparisons between these groups were made using t-tests or Chi square tests. A multivariate logistic regression model was developed using dysglycemia [diabetes and or prediabetes (IGT or IFG or both)] as the dependent variable and predictor variables which were significant in the bivariate analysis as the independent variable.
Definitions
The following definitions were used to classify diabetes (DM) or prediabetes [impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT)] or normal glucose tolerance (NGT) after the postpartum follow-up OGTT [24] . For the purpose of this paper, women who developed dysglycemia (diabetes or prediabetes) are referred to as ''converters" and those who reverted to NGT are referred to as ''non converters". (Table 1) . Age, BMI, gestational week at booking, HbA1c, family history of diabetes and PCOD were higher among women with GDM who converted to dysglycemia when compared to those who reverted back to NGT. However, only BMI, HbA1c (at booking) and previous history of GDM reached statistical significance (Table 2) .
Results
203
Multivariate logistic regression showed that a baseline BMI of P25 kg/m 2 [odds ratio (OR) 4.4, CI: 1.78-11.20, p value = 0.001] was significantly associated with postpartum dysglycemia after adjusting for HbA1c and previous history of GDM (Table 3 ).
Discussion
Several studies have shown that GDM is an important risk factor for development of T2DM. Depending on various factors like ethnicity, protocols used, follow-up duration and the diagnostic criteria used, conversion rates vary from 2.6% to as high as 70% [25] . Studies from the west have shown that during a 5 year follow-up after GDM, the cumulative incidence rate of diabetes was 50% [26] . In a previous retrospective study, we showed that 56.3% of women with a history of GDM developed diabetes within 5 years after delivery [27] . Kale et al. [28] from northern India reported conversion rates of 52% after a mean follow-up period of 4.5 years. The present study is of interest because we show that conversion to dysglycemia occurs rapidly. In this cohort, 15.5% of women were detected to have dysglycemia by 12 weeks while an additional 38.1% were detected to have dysglycemia between 12 weeks and 1 year of delivery, highlighting the importance of early screening for diabetes. It also shows the value of screening within 1 year window period in women who missed screening or screened negative at 12 weeks postpartum. Given that T2DM is an important sequel of GDM, close postpartum follow-up is essential. It is also important to identify women at greatest risk of postpartum T2DM, to help plan prevention and intervention strategies that could improve health outcomes.
Previous investigations have demonstrated that conversion to dysglycemia is attributed to several risk factors including maternal age, BMI, family history of T2DM, previous history of GDM, HbA1c, weight gain during pregnancy and birth weight of the baby [29, 30] . Several studies have revealed that maternal BMI at baseline (independent of weight gain) is an independent risk factor for subsequent conversion to dysglycemia [26, [31] [32] [33] . A study from Denmark reported that BMI of P25 kg/m 2 was one of the main predictors of postpartum glucose abnormalities [4] . HbA1c is also reported as a predictor for diabetes following GDM [34, 35] . As seen in previous studies, the current study also revealed that BMI P25 kg/m 2 is an independent risk factors for postpartum dysglycemia in south Indian women. While other traditional risk factors demonstrated a trend towards increased risk for GDM, they did not reach statistical significance probably due to smaller sample size.
Several organizations have put forth guidelines for postpartum follow-up. The American Diabetes Association (ADA) recommends that women with GDM should undergo screening for T2DM with OGTT, 6 weeks after delivery [9] . The National Institute for Health and Care Excellence (NICE) recommends fasting plasma glucose (FPG) testing at 6 weeks postpartum [36] , while WHO recommends an OGTT at 6 weeks or after [37] .
Despite all these well established guidelines put forth by several highly respected organizations, postpartum screening rates have ranged from 23% to 58% between 5 weeks and 1 year following delivery [38] [39] [40] [41] [42] [43] . Several potential explanations have been offered for such poor rates of postpartum follow-up screening. One is the uncertainty between primary and secondary care responsibilities for screening. In some settings, GDM follow-up is not considered a clinical priority [44] . This could be due to lack of awareness among health care professionals about various guidelines. Patient related barriers include emotional stress and difficulty with adjusting to motherhood and difficulty to come for postpartum testing in fasting state when exclusively breastfeeding through the night [45] .
In the present study also, several barriers to postpartum screening were observed. Logistic issues such as distance from the hospital, demands of household tasks and lack of shared responsibility for the newborn impede postpartum screening. However, we were able to ensure a 95.8% followup rate which surpasses typically expected rates of followup seen in high, middle and low income settings. Review of latest evidence regarding rates of postpartum follow-up by Tovar et al. [46] shows that postpartum follow-up rates varied greatly but were generally reported to be poor: between 34% and 73%. One reason for the high success rate in this study could be because we constantly reminded our women during their pregnancy to return for postpartum follow-up between 6 and 12 weeks after delivery. Efforts were taken to increase the postpartum screening rates by sending reminders to the patients, by contacting them through phone calls and arranging home visits for testing. In our experience one important aspect which affects the postpartum follow-up is that many women move to their maternal homes for delivery, a social custom practiced in many parts of India. This was a major limitation of the study, as postpartum follow up testing which was planned to be completed within 12 weeks was delayed up to a year for women who went to their maternal homes for delivery did not return back for postpartum testing until the end of one year. In view of the rapid conversion to T2DM occurring in this population after GDM, it is important to emphasize in future programmes, the value of early post-partum screening even within 12 weeks, with cultural adaptations to achieve the same, including testing at the city where the mother resides. This would increase the scope for introducing preventive measures to reduce the risk of progression to dysglycemia. Another limitation is that we did not include diet and physical activity assessment or advise as part of WINGS post-partum follow up. Finally we did not collect data on exclusive breast feeding which is yet another limitation of our study.
In summary, the WINGS project has demonstrated that through sustained efforts, a near total post-partum followup is achievable. The importance of this in Asian Indian women, is demonstrated by the high rates and rapid conversion to dysglycemia seen amongst our population. Early screening in the postpartum period particularly in overweight women can identify women who are likely to progress to dysglycemia and thus help plan preventive strategies for delaying the onset of T2DM in them.
